Safety evaluation of a sinus surfactant in an explant-based cytotoxicity assay

Laryngoscope

Volumn 124, Issue 2, 2014, Pages 369-372

  Tan, Neil C W ^a   Cooksley, Clare M ^a   Paramasivan, Sathish ^a   Vreugde, Sarah ^a   Wormald, Peter John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

biofilm; Chronic rhinosinusitis; cytotoxicity; human sinonasal explants; sinus surfactant

Indexed keywords

LACTATE DEHYDROGENASE; SODIUM CHLORIDE; SURFACTANT; ZINC SULFATE;

AIR; ARTICLE; BRUSH BORDER; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; DEGRADATION; ENDOSCOPIC SINUS SURGERY; EXPLANT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIQUID; NOSE MUCOSA; PRIORITY JOURNAL; SAFETY; SCANNING ELECTRON MICROSCOPY; SUPERNATANT; ULTRASTRUCTURE; BIOFILM; CYTOLOGY; DRUG EFFECTS; PARANASAL SINUS; TOXICITY;

BIOFILMS; HUMANS; IN VITRO TECHNIQUES; NASAL MUCOSA; PARANASAL SINUSES; SURFACE-ACTIVE AGENTS;

EID: 84892942912     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24255     Document Type: Article

References (16)

1. Foreman A, Holtappels G, Psaltis AJ, et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy 2011; 66: 1449-1456.
2. Singhal D, Foreman A, Bardy JJ, Wormald PJ,. Staphylococcus aureus biofilms: nemesis of endoscopic sinus surgery. Laryngoscope 2011; 121: 1578-1583.
3. Jensen ET, Kharazmi A, Lam K, et al. Human polymorphonuclear leukocyte response to pseudomonas aeruginosa grown in biofilms. Infect Immun 1990; 58: 2383-2385.
4. Stewart PS, Costerton JW,. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-138.
5. Kofonow JM, Adappa ND,. In vitro Antimicrobial Activity of SinuSurf. ORL J Otorhinolaryngol Relat Spec 2012; 74: 179-184.
6. Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008; 22: 34-37.
7. Le T, Psaltis, A, Tan, LW, Wormald, PJ,. The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis. Am J Rhinol 2008; 22: 560-567.
8. Desrosiers M, Myntti M, James G,. Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol 2007; 21: 527-532.
9. Rogers DF,. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007; 52: 1176-1193; discussion 1193-1177.
10. Lim JH, Davis GE, Rue TC, Storm DR,. Human sinonasal explant system for testing cytotoxicity of intranasal agents. Int Forum Allergy Rhinol 2012; 2: 63-68.
11. Ha KR, Psaltis AJ, Tan L, Wormald PJ,. A sheep model for the study of biofilms in rhinosinusitis. Am J Rhinol 2007; 21: 339-345.
12. Foreman A, Jervis-Bardy J, Wormald PJ,. Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis? Laryngoscope 2011; 121: 1085-1091.
13. Rose WE, Poppens PT,. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother 2009; 63: 485-488.
14. Dunne WM Jr,. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002; 15: 155-166.
15. Kilty SJ, Desrosiers MY,. Are biofilms the answer in the pathophysiology and treatment of chronic rhinosinusitis? Immunol Allergy Clin North Am 2009; 29: 645-656.
16. Chiu AG, Chen B, Palmer JN, et al. Safety evaluation of sinus surfactant solution on respiratory cilia function. Int Forum Allergy Rhinol 2011; 1: 280-283.